4.7 Article

Pharmacological basis for the medicinal use of Carissa carandas in constipation and diarrhea

Journal

JOURNAL OF ETHNOPHARMACOLOGY
Volume 153, Issue 2, Pages 359-367

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.jep.2014.02.024

Keywords

Carissa carandas; Laxative; Cholinergic; Histaminergic; Antidiarrheal; Ca+ + antagonist

Funding

  1. Higher Education Commission, Government of Pakistan, under the scheme of Distinguished National Professor research allowance awarded
  2. Faculty Research Support Fund

Ask authors/readers for more resources

Ethnopharmacological relevance: Carissa carandas Linn. commonly known as Karaunda (Apocynaceae) is a popular medicinal herb widely distributed in different parts of Pakistan. In addition to other medicinal uses, Carissa carandas is popular in indigenous system of medicine for its medicinal use in gut motility disorders like, constipation and diarrhea. Objective: This study was planned to provide pharmacological basis to the medicinal use of Carissa carandas in constipation and diarrhea. Materials and methods: The crude extract of the leaves of Carissa carandas (Cc.Cr) was prepared in methanol and its fractionation was carried out with ethylacetate, petroleum ether and n-butanol. In-vivo studies were conducted on mice, while isolated rabbit jejunum and guinea-pig ileum preparations were used for the in-vitro experiments. The spasmogenic and spasmolytic responses of gut tissues were recorded using isotonic transducers coupled with PowerLab data acquisition system. Results: The HPLC fingerprints of Cc.Cr, its petroleum (Cc.Pef), ethylacetate (Cc.Eaf) and n-butanol (Cc.Baf) fractions showed the presence of oleanolic acid, ursolic acid, stigmasterol and fl-sitosterol. Oral administration of Cc.Cr to mice increased fecal output at lower doses (30 and 50 mg/kg), while it showed protection against castor oil-induced diarrhea at higher doses (300 and 600 mg/kg). In isolated guinea-pig ileum and rabbit jejunum, Cc.Cr and Cc.Baf exhibited stimulatory effect at 0.003-3 mg/ml, which was partially sensitive to atropine or pyrillamine or partially/fully sensitive to atropine pyrillamine, followed by relaxation at higher tested concentrations, being more potent in rabbit tissues. The ethylacetate fraction (0.1-5 mg/ml) exhibited fully atropine-sensitive contractions in both guinea-pig and rabbit tissues, being more potent in guinea-pig while more efficacious in rabbit tissues. However, the petroleum fraction (0.003-1.0 mg/ml) showed only spasmolytic activity in spontaneously contracting rabbit tissues, similar to nifedipine. In guinea-tissue, Cc.Pef did not cause any stimulant effect. When studied against high K+ (80 mM)-induced contraction, the crude extract and its fractions caused a dose-dependent inhibition, with the following order of potency: Cc.Pef > Cc.Eaf > Cc.Cr > Cc.Baf, similar to nifedipine indicating Ca + + channel antagonist like activity, which was further confirmed when the plant extract displaced Ca + + curves to the right with suppression of maximum effect similar to that of nifedipine. Conclusion: This study demonstrates that the crude extract of Carissa carandas possesses a gutstimulatory effect mediated primarily through the activation of muscarinic and histaminergic receptors while its spasmolytic effect was mediated possibly through Ca + + antagonist pathway. Thus, this study provides a clear evidence for the dual effectiveness of Carissa carandas in constipation and diarrhea, thus validating its medicinal use. (C) 2014 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available